General MedicationsINJECTIONGeneric

LEVAQUIN

LEVOFLOXACIN

Standard Dose

EQ 500MG/20ML (EQ 25MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview LEVAQUIN is listed in Drugs@FDA under application 020635 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOFLOXACIN Form and strength INJECTABLE;INJECTION - EQ 500MG/20ML (EQ 25MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JANSSEN PHARMS Submission history Latest submission status date: 2017-02-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVAQUIN is listed in Drugs@FDA under application 020635 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOFLOXACIN Form and strength INJECTABLE;INJECTION - EQ 500MG/20ML (EQ 25MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JANSSEN PHARMS Submission history Latest submission status date: 2017-02-08 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.